Global Human Genetics Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Application;

Wellness & E-Commerce, Preventive Medicine, and Diagnostic & Treatment.

By Human Genetics Test;

NIPT, Carrier Testing, Pharmacogenomic Testing, Karyotype Testing, Thrombophilia Testing, Septin 9 Biomarker Testing, NGS, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn741269260 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Human Genetics Market (USD Million), 2021 - 2031

In the year 2024, the Global Human Genetics Market was valued at USD 33,664.50 million. The size of this market is expected to increase to USD 86,592.98 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 14.5%.

Human genetics, a field integral to understanding genetic variations, hereditary diseases, and personalized medicine, has witnessed profound advancements in recent years. These advancements are driven by breakthroughs in genomic technologies, such as next-generation sequencing (NGS), CRISPR gene editing, and bioinformatics, which have revolutionized our ability to decode the human genome and unravel its complexities.

This market plays a pivotal role in diagnosing and managing genetic disorders, predicting disease risks, and tailoring treatments based on individual genetic profiles. Genetic testing and counseling services are increasingly integrated into mainstream healthcare, offering insights into inherited conditions and enabling proactive health management. Moreover, genetic research fuels innovation across diverse sectors, including pharmaceuticals, biotechnology, and academic research, driving the development of novel therapies and precision medicine approaches.

Key drivers of growth in the Global Human Genetics Market include rising incidences of genetic disorders, advancements in personalized medicine, and increasing adoption of genetic testing for disease prevention and early intervention. The market is characterized by a multitude of stakeholders, including biopharmaceutical companies, research institutions, healthcare providers, and genetic testing laboratories, each contributing to the expanding applications of human genetics in clinical practice and scientific discovery. As technological capabilities continue to evolve and regulatory frameworks adapt to support genomic medicine, the Global Human Genetics Market is poised for further expansion. Innovations in genomic sequencing, genetic biomarkers, and therapeutic targeting are expected to drive market growth, offering new avenues for disease management and personalized healthcare solutions globally.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Application
    2. Market Snapshot, By Human Genetics Test
    3. Market Opportunity Map
  4. Global Human Genetics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Prevalence of Genetic Disorders

        2. Expanding Research Activities in Genetics

        3. Growing Applications in Personalized Medicine

      2. Restraints
        1. Complexity of Genetic Data Interpretation

        2. Data Privacy and Security Concerns

      3. Opportunities
        1. Advancements in Genomic Technologies

        2. Expanding Applications in Oncology and Rare Diseases

        3. Biopharmaceutical Collaborations and Research Initiatives

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Human Genetics Market, By Application, 2021 - 2031 (USD Million)
      1. Wellness & E-Commerce
      2. Preventive Medicine
      3. Diagnostic & Treatment
    2. Global Human Genetics Market, By Human Genetics Test, 2021 - 2031 (USD Million)
      1. NIPT
      2. Carrier Testing
      3. Pharmacogenomic Testing
      4. Karyotype Testing
      5. Thrombophilia Testing
      6. Septin 9 Biomarker Testing
      7. NGS
      8. Others
    3. Global Human Genetics Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Agilent Technologies

      2. Bode Technology

      3. GE Healthcare

      4. Illumina

      5. LGC Forensics

      6. Orchid Cellmark, Inc.

      7. Promega Corporation

  7. Analyst Views
  8. Future Outlook of the Market